Discontinued — last reported Q4 '24
Financing
Payment For Offering And Loan Costs
Over 2 years (FY 2021 to FY 2024), Payment For Offering And Loan Costs shows a downward trend with a -100.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ4 2020
Last reportedQ4 2024May 29, 2025
How to read this metric
Higher costs relative to proceeds may indicate inefficient capital raising or complex deal structures.
Detailed definition
Cash outflows related to fees paid to underwriters, legal advisors, and other service providers for the issuance of debt...
Peer comparison
Standard administrative cost for any company accessing public or private capital markets.
Metric ID:
financing_payment_for_offering_and_loan_costsHistorical Data
13 periods
| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.60M | $7.24M | $8.42M | $32.00K | $2.25M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | +57.5% | +16.3% | -99.6% | >999% | -100.0% | — | — | — | — | — | — | — |
| YoY Change | — | — | — | — | -51.1% | -100.0% | — | — | — | — | — | — | — |
Range$0.00 – $8.42M
CAGR-100.0%
Avg YoY Growth-75.5%
Median YoY Growth-75.5%
Payment For Offering And Loan Costs at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's payment for offering and loan costs?
- Roivant Sciences (ROIV) reported payment for offering and loan costs of $0.00 in Q1 2025.
- What is the long-term trend for Roivant Sciences's payment for offering and loan costs?
- Over 2 years (2021 to 2024), Roivant Sciences's payment for offering and loan costs has grown at a -100.0% compound annual growth rate (CAGR), from $20.30M to $0.00.
- What does payment for offering and loan costs mean?
- Fees paid to facilitate raising debt or equity capital.